BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12056298)

  • 1. [Drug therapy and malpractice exemplified by combination leflunomide and methotrexate therapy].
    Burgardt C
    Z Rheumatol; 2002 Apr; 61(2):189-90. PubMed ID: 12056298
    [No Abstract]   [Full Text] [Related]  

  • 2. [Leflunomide + methotrexate combination therapy from the physician's viewpoint].
    Reinhold-Keller E; Gromnica-Ihle E
    Z Rheumatol; 2002 Apr; 61(2):191-3. PubMed ID: 12056299
    [No Abstract]   [Full Text] [Related]  

  • 3. [Can a combination therapy with leflunomide be recommended for patients with active rheumatoid arthritis?].
    Hamann F
    Z Rheumatol; 2003 Apr; 62(2):204-5. PubMed ID: 12820624
    [No Abstract]   [Full Text] [Related]  

  • 4. Leflunomide in combination therapy for rheumatoid arthritis.
    Savage RL
    Drug Saf; 2010 Jun; 33(6):523-6. PubMed ID: 20486733
    [No Abstract]   [Full Text] [Related]  

  • 5. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
    Singer O; Gibofsky A
    Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe leukopenia in a rheumatoid arthritis patient treated with a methotrexate/leflunomide combination.
    Toth P; Bernd R
    Rev Bras Reumatol; 2014; 54(2):152-4. PubMed ID: 24878863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis.
    Mroczkowski PJ; Weinblatt ME; Kremer JM
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S66-8. PubMed ID: 10589360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
    Bird P; Griffiths H; Tymms K; Nicholls D; Roberts L; Arnold M; Burnet S; de Jager J; Scott J; Zochling J; Littlejohn G
    J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.
    Behrens F; Koehm M; Burkhardt H
    Curr Opin Rheumatol; 2011 May; 23(3):282-7. PubMed ID: 21427581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration.
    Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Hetland ML; Tarp U; van Riel PL; Nordström DC; Gomez-Reino J; Pavelka K; Tomsic M; Kvien TK; van Vollenhoven RF; Gabay C
    Ann Rheum Dis; 2012 Mar; 71(3):374-7. PubMed ID: 21972242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of treatment with methotrexate, leflunomide, detralex, and their combination of patients with rheumatoid arthritis].
    Shevchuk SV; Stanislavchuk MA; Pentiuk OO
    Lik Sprava; 2003; (3-4):34-41. PubMed ID: 12889354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leflunomide and methotrexate.
    Laan RF; van Riel PL; van de Putte LB
    Curr Opin Rheumatol; 2001 May; 13(3):159-63. PubMed ID: 11333342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancytopenia associated with leflunomide and methotrexate.
    Hill RL; Topliss DJ; Purcell PM
    Ann Pharmacother; 2003 Jan; 37(1):149. PubMed ID: 12503951
    [No Abstract]   [Full Text] [Related]  

  • 14. [Security of the combined treatment of methotrexate and leflunomide in patients with rheumatoid arthritis].
    Nesa L; Gobbi C; Alba P; Exeni I; Babini A; Albiero E
    Rev Fac Cien Med Univ Nac Cordoba; 2007; 64(4):109-14. PubMed ID: 19928400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hepatotoxicity in a rheumatoid arthritis patient switched from leflunomide to methotrexate.
    Gupta R; Gupta SK
    MedGenMed; 2005 Sep; 7(3):9. PubMed ID: 16369235
    [No Abstract]   [Full Text] [Related]  

  • 16. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease modifying treatment for feline rheumatoid arthritis.
    Hanna FY
    Vet Comp Orthop Traumatol; 2005; 18(2):94-9. PubMed ID: 16594204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial.
    Wijesinghe H; Galappatthy P; de Silva R; Seneviratne SL; Saravanamuttu U; Udagama P; Hart M; Kelleher P; Senerath U; Fernandopulle R; Weerasekera LP; Wijayaratne LS
    BMC Musculoskelet Disord; 2017 Jul; 18(1):310. PubMed ID: 28724365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [2 years data of controlled trials with leflunomide vs. methotrexate and leflunomide vs. sulfasalazine].
    Krüger K
    Z Rheumatol; 2002 Jun; 61(3):308-10. PubMed ID: 12219638
    [No Abstract]   [Full Text] [Related]  

  • 20. [Leflunomide in combination with TNF-blockers for Methotrexate intolerance].
    Krüger K; Manger B;
    Z Rheumatol; 2009 Mar; 68(2):165-8. PubMed ID: 19159938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.